Link: LianBio Announces China National Medical Products Administration (NMPA) Acceptance with Priority Review of New Drug Application for Mavacamten for the...
Link: LianBio Announces China National Medical Products Administration (NMPA) Acceptance with Priority Review of New Drug Application for Mavacamten for the...
The rest is here: Ocuphire Appoints Rick Rodgers as Interim Chief Executive Officer
Continued here: CymaBay Therapeutics Announces Publication of Results From the ENHANCE, Phase 3 Study of Seladelpar in Patients with Primary Biliary Cholangitis (PBC)
See the article here: LianBio Promotes Pascal Qian to Chief Commercial Officer
See the rest here: SciSparc and Clearmind Collaboration Strengthens IP Portfolio with Patent Application in the U.S. for Treatment of Depression
Read the original: Clearmind Medicine Expanding IP Portfolio with New US Patent Application for Treatment of Depression
The rest is here: Disc Medicine to Participate in H.C. Wainwright BioConnect Investor Conference
Original post: Lexicon To Present Results From LX9211 Phase 2 Trial In Postherpetic Neuralgia At The 2023 American Academy Of Neurology (AAN) Annual Meeting And The...
The rest is here: Ultimovacs ASA - Share Option Program
Originally posted here: Vallon Pharmaceuticals Completes Merger with GRI Bio, Inc.
Recent Comments